The Business Nearby

Longevity

1 article

Scientists in a futuristic lab working on cellular regeneration technology, symbolizing the groundbreaking research in aging reversal funded by METiS TechBio's IPO.
New Openings

METiS TechBio Raises $270M in IPO for Reversing Aging Science

On May 13, METiS TechBio soared, raising US$269.

Rizza Valencia·June 7, 2026